跳至主要内容
临床试验/TCTR20200909001
TCTR20200909001招募中未知

Prediction of response to Erythropoiesis stimulating agents by erythropoietin level and gene mutations in Low-risk Myelodysplastic syndromes: Cross sectional study

Ratchadaphiseksomphot Endowment Fund0 个研究点目标入组 42 人开始时间: 2020年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
15 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. The patient who has diasnosed as Myelodysplastic syndrome during 1 January 2014 ถึง 31 January 2019
  • 2. The patient has age more than 15 years-old
  • 3. IPSS-R score 0-4.5 (MDS low risk)
  • 4. The patient was treated by Erythropoietin stimulating agent

排除标准

  • 1. Therapy related MDS
  • 2. History of pure red cell aplasia

研究者

发起方
Ratchadaphiseksomphot Endowment Fund

相似试验